{"schema_version":"1","generated_at":"2026-11-02T10:45:58.894Z","data_as_of":null,"url":"https://www.findmykol.com/kol/allison-puechl","json_url":"https://www.findmykol.com/kol/allison-puechl/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"allison-puechl","name":"Allison Puechl","credential":"MD","specialty":"Obstetrics & Gynecology","specialty_raw":"Obstetrics & Gynecology","therapeutic_area":"Gynecologic","therapeutic_areas":["Gynecologic"],"institution":"Levine Cancer Institute","institution_url":"https://www.findmykol.com/institution/levine-cancer-institute","city":"Charlotte","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1245572528","orcid":"0000-0003-0761-7727","openalex":"A5062645580"},"summary":"Allison Puechl is a Gynecologic physician affiliated with Levine Cancer Institute. OpenAlex indexes 57 publications with 291 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Gynecologic"]},"scholarship":{"works_count":57,"cited_by_count":291,"h_index":9,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1245572528","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma","year":2026,"journal":"bioRxiv (Cold Spring Harbor Laboratory)","source_url":"https://doi.org/10.64898/2026.08.28.747865","status":"verified"},{"title":"Everolimus and aromatase inhibitors for advanced and recurrent low-grade serous ovarian carcinoma.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.5569","status":"verified"},{"title":"Incidence of grade II or higher hematologic toxicities in ovarian cancer patients on concurrent poly-ADP ribose polymerase inhibitor therapy and anti-Xa inhibition therapy","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.01.601","status":"verified"},{"title":"PTEN as a biomarker for sensitivity to multitargeted small molecule CDK4/6-CDK9-AURKA/B inhibitor, LCI133, and other CDK9 inhibitors","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.01.153","status":"verified"},{"title":"Abstract 1900: PTEN loss of function encodes sensitivity to multitargeted small molecule CDK4/6-CDK9-AURKA/B inhibitor, LCI133, and other CDK9 inhibitors.","year":2026,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2026-1900","status":"verified"}],"source":"works"},"similar":[{"name":"Peter Voorhees","slug":"peter-voorhees","institution":"Levine Cancer Institute","specialty":"Hematology","url":"https://www.findmykol.com/kol/peter-voorhees","json_url":"https://www.findmykol.com/kol/peter-voorhees/profile.json"},{"name":"Benjamin Moeller","slug":"benjamin-moeller","institution":"Levine Cancer Institute","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/benjamin-moeller","json_url":"https://www.findmykol.com/kol/benjamin-moeller/profile.json"},{"name":"Jubilee Brown","slug":"jubilee-brown","institution":"Levine Cancer Institute","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/jubilee-brown","json_url":"https://www.findmykol.com/kol/jubilee-brown/profile.json"},{"name":"Robert Naumann","slug":"robert-naumann","institution":"Levine Cancer Institute","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/robert-naumann","json_url":"https://www.findmykol.com/kol/robert-naumann/profile.json"},{"name":"Baha Sibai","slug":"baha-sibai","institution":"McGovern Medical School at UTHealth Houston","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/baha-sibai","json_url":"https://www.findmykol.com/kol/baha-sibai/profile.json"},{"name":"Robert Coleman","slug":"robert-coleman","institution":"Vaniam Group","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/robert-coleman","json_url":"https://www.findmykol.com/kol/robert-coleman/profile.json"},{"name":"Kathleen Moore","slug":"kathleen-moore","institution":"University of Nebraska Medical Center","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/kathleen-moore","json_url":"https://www.findmykol.com/kol/kathleen-moore/profile.json"},{"name":"Bradley Monk","slug":"bradley-monk","institution":"Florida Cancer Specialists & Research Institute","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/bradley-monk","json_url":"https://www.findmykol.com/kol/bradley-monk/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}